JPMorgan analyst Brian Cheng downgraded Cargo Therapeutics (NASDAQ: CRGX) from Neutral to Underweight.The analyst comments "We are downgrading CRGX to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE